1. Home
  2. BZUN vs MDWD Comparison

BZUN vs MDWD Comparison

Compare BZUN & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$2.78

Market Cap

159.3M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$14.75

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZUN
MDWD
Founded
2007
2000
Country
China
Israel
Employees
6762
N/A
Industry
Catalog/Specialty Distribution
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.3M
181.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BZUN
MDWD
Price
$2.78
$14.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
277.8K
92.5K
Earning Date
05-20-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.89
$48.92
Revenue Next Year
$6.16
$35.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$13.54
52 Week High
$4.88
$21.26

Technical Indicators

Market Signals
Indicator
BZUN
MDWD
Relative Strength Index (RSI) 54.99 55.45
Support Level $2.62 $14.90
Resistance Level $2.82 $18.49
Average True Range (ATR) 0.13 0.52
MACD 0.01 0.20
Stochastic Oscillator 52.44 91.36

Price Performance

Historical Comparison
BZUN
MDWD

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: